Article

Functional Precision Medicine Enhances Clinical Outcomes of Relapsed/Refractory Pediatric and Adolescent Cancer Patients

2023-07-07

Abstract excerpt

<title>Abstract</title> <p>Current genomics-driven precision oncology identifies actionable mutations in < 10% of cancer patients. Pediatric cancer is especially challenging due to limited mutations and fewer genomics-guided options. Functional precision medicine (FPM) addresses this by integrating genomic profiling with rapid, high-throughput functional <italic>ex vivo</italic> drug testing on live patient-deriv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a0336d7e-af1c-5a04-a9d8-8ef9fddf263e
DOI: 10.21203/rs.3.rs-3133886/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Functional Precision Medicine Enhances Clinical Outcomes of Relapsed/Refractory Pediatric and Adolescent Cancer PatientsDOI 10.21203/rs.3.rs-3133886/v1Read

MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research.Semantic proximity Read

From Sequence to Salvation: Delivering on the Promise of Precision Medicine in Childhood CancerSemantic proximity Read

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.Semantic proximity Read

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.Semantic proximity Read

Genomics-Driven Precision Medicine in Pediatric Solid TumorsSemantic proximity Read

Data-driven approaches to advance research and clinical care for pediatric cancer.Semantic proximity Read

Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthSemantic proximity Read

Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors.Semantic proximity Read

Pediatric Patient-Derived-Xenograft development in MAPPYACTS – international pediatric cancer precision medicine trial in relapsed and refractory tumorsSemantic proximity Read

An institutional review of genomic sequencing in pediatric solid tumors.Semantic proximity Read

Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.Semantic proximity Read

Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.Semantic proximity Read